Nordion Inc (NDN.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Nordion Inc (NDN.TO)

0.00

-0.00 (0.00%)

4 watching

BUY

Price looks good. Well diversified and well managed.

BUY ON WEAKNESS

Always looked expensive. Would be a buyer in the $15 range.

BUY

A way to participate in the Cdn biotechs. Not heavily traded.

WEAK BUY

Has been disappointing. Has some overhang (Hemasol, Proteonomics, venture capital stuff) before it can really get going.

TOP PICK

Had one or two disappointments however, but some divisions are doing very well. Research equipment is selling even in a down market.

DON'T BUY

Doesn't seem to be participating with the market.

BUY

Worth $22/25. Doesn't expect anything big.

BUY ON WEAKNESS

The trend on this stock has been down. Pharma Services division is not holding up. Also, a joint venture in the US didn't do well. Treat as a trading stock.

BUY

Trades in a tight range. Drug companies are in a bit of a squeeze. Has one or two misses in getting value out of some of their assets. A quality stock.

BUY

Feels the pharma and scienx divisions are going to be the two drivers for it. Should have modest earnings going forward.

BUY

Likes this sector and should grow reasonably well.

BUY

Have yet to hit a home run. A potential of base profit growth on their lab assets because of Ontario government. Reasonable investment.

BUY

Has dropped because of market sell off of Hemasol and Sciex division. At a good price.

BUY

Heamasol was a problem. Good price. Growth prospects.

BUY

The stock got hit because one of their distributors gave a profit warning. Has been oversold and is a good price.

Showing 61 to 75 of 229 entries

Most Recent Experts

Joe Terranova

Virtus Investment Partners

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Bryn Talkington

Requisite Capital Management

Shannon Saccocia, CIO, Boston Private

Boston Private

David Burrows

Barometer Capital Management

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Nordion Inc (NDN.TO)